Kyntra Bio (KYNB) Total Debt (2023 - 2026)

Kyntra Bio has disclosed Total Debt across 4 years of filings, most recently posting $19.2 million for Q2 2026.

• In Q2 2026, Total Debt fell 73.96% year-over-year to $19.2 million; the TTM figure through Jun 2026 stood at $19.2 million (down 73.96% YoY), while the FY2024 annual figure was $73.1 million, up 1.61% from the prior year.
• Total Debt came in at $19.2 million for Q2 2026 at Kyntra Bio, down from $73.7 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $73.7 million in Q2 2025 to a low of $19.2 million in Q2 2026.
• Average Total Debt over 4 years is $67.2 million, with a median of $72.3 million recorded in 2024.
• Year-over-year, Total Debt climbed 1.73% in 2025 and slumped 73.96% in 2026.
• Over 4 years, Total Debt stood at $71.9 million in 2023, then gained by 1.61% to $73.1 million in 2024, then advanced by 0.88% to $73.7 million in 2025, then tumbled by 73.96% to $19.2 million in 2026.
• Per Business Quant data, the three most recent Total Debt figures were $19.2 million in Q2 2026, $73.7 million in Q2 2025, and $73.4 million in Q1 2025.